ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 67

Polymorphisms of ERAP1, IL23R and TRAILR1 Are Associated with MRI-Sacroiliitis in Early Axial Spondyloarthritis: Data from the French DESIR Cohort

Cécile Luxembourger1, Yannick Degboé2, Alain Cantagrel3, Delphine Nigon4, Pascal Claudepierre5, Arnaud CONSTANTIN6 and Adeline Ruyssen-Witrand7, 1Rheumatology, Centre Hospitalier Universitaire, Toulouse Purpan, Toulouse, France, 2Rheumatology, Rheumatology Center, Purpan University Hospital, Toulouse, France, 3Rheumatology, INSERM CNRS UMR 1043, Paul Sabatier University Toulouse, Purpan Teaching Hospital, Toulouse, France, 4CHU Purpan, Toulouse, France, 5Hôpital Henri Mondor, Créteil, France, 6Rheumatology, CHU Purpan - Hôpital Pierre-Paul Riquet, Toulouse, France, 7Rheumatology Center, Purpan University Hospital, Toulouse, France

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Genetic Biomarkers, magnetic resonance imaging (MRI) and spondylarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 13, 2016

Title: Genetics, Genomics and Proteomics - Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Polymorphisms of ERAP1, IL23R and TRAILR1 are associated With MRI-Sacroiliitis in Early Axial Spondyloarthritis: Data from the French DESIR Cohort

Background/Purpose: Spondyloarthritis (SpA) is a highly heritable disease, often affecting the sacroiliac joints. Single nucleotide polymorphisms on ERAP1, IL23R and TRAIL-R1(or Tumor Necrosis Factor-related Apoptosis-inducing Ligand Receptor 1) are associated with SpA susceptibility and structural changes on sacroiliac joints on radiographs. The aim of this study was to test the association between these polymorphisms and the presence of sacroiliitis on magnetic resonance imagery (MRI), in a French early SpA cohort (DESIR: Devenir des Spondyloarthrites Récentes).

Methods: All patients included in the DESIR cohort fulfilling the Assessment of SpondyloArthritis international Society (ASAS) diagnosis criteria for axial SpA, AMOR or European Spondyloarthropathy Study Group (ESSG) criteria, were included in this study. All MRI were scored by two experienced readers, according to Spondyloarthritis Research Consortium of Canada (SPARCC) score and ASAS definition. Genotyping: Three SNPs on IL23R (rs1004819, rs10889677, rs2201841), 4 SNPs on ERAP1 (rs17482078, rs10050860, rs27434, rs2287987), 1 SNP on TRAILR1 (rs20575) were genotyped using KasPar method (LGC-genomics, UK). The haplotype of the 3 SNPs on IL23R and the 4 SNPs on ERAP1were built with Plink software. Statistics: Univariate analyses using a Chi square test and a Wilcoxon tests were performed to assess whether a haplotype of ERAP1, IL23R and a genotype of the SNP on TRAILR1were associated with MRI sacroiliitis or SPARCC score respectively.

Results: Among the 708 patients included in the DESIR cohort, 645 fulfilled at least one of the criteria set for SpA. Among them, 403 (62,6%) patients were HLA-B27 positive. 214 patients (34.2%) had a MRI sacroiliitis and 161 (25%) patients had SPARCC MRI sacroiliitis score higher than 4. The haplotype TAG of IL23R was associated with MRI sacroiliitis with SPARCC criteria (SPARCC median=0.75 [0-8] in TAG patients versus 0[0-2] in non-TAG patients, p=0.0021), while rs20575 on TRAILR1 was associated with MRI sacroiliitis using SPARCC criteria (SPARCC median=1[0-6.5] in G allele carriers versus 0[0-2] in G allele non-carriers, p=0.0046). These associations were stronger in HLA-B27 positive patients (SPARCC median in TAG carriers of IL23R = 1[0-10.5] versus 0[0-4] in TAG non-carriers, p=0.0058; in G allele of TRAILR1 carriers: 1.5[0-10.5], versus 0[0-4] in G allele non-carriers, p=0.0044). The haplotype CCAT of ERAP1 was associated with MRI sacroiliitis with ASAS criteria (47.1% of patients with sacroiliitis in CCAT carriers, versus 30.4% in non-carriers, p=0.046). Stratification on the presence of HLA-B27 enhanced this association (60% of patients with sacroiliitis in CCAT carriers, versus 31.6% in non-carriers in HLA-B27positive patients, p = 0.0035).

Conclusion: In the DESIR cohort, ERAP1, TRAILR1 and IL23R polymorphisms were associated with the presence of MRI sacroiliitis in SpA, particularly in HLA-B27patients. This work received an institutional support by the French Society of rheumatology.


Disclosure: C. Luxembourger, None; Y. Degboé, None; A. Cantagrel, None; D. Nigon, None; P. Claudepierre, None; A. CONSTANTIN, None; A. Ruyssen-Witrand, None.

To cite this abstract in AMA style:

Luxembourger C, Degboé Y, Cantagrel A, Nigon D, Claudepierre P, CONSTANTIN A, Ruyssen-Witrand A. Polymorphisms of ERAP1, IL23R and TRAILR1 Are Associated with MRI-Sacroiliitis in Early Axial Spondyloarthritis: Data from the French DESIR Cohort [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/polymorphisms-of-erap1-il23r-and-trailr1-are-associated-with-mri-sacroiliitis-in-early-axial-spondyloarthritis-data-from-the-french-desir-cohort/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/polymorphisms-of-erap1-il23r-and-trailr1-are-associated-with-mri-sacroiliitis-in-early-axial-spondyloarthritis-data-from-the-french-desir-cohort/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology